Holen Sie sich die Stockscreener-App
180.64
1.91%
3.39
Handel nachbörslich:
180.62
-0.02
-0.01%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DHR?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$177.25
Offen:
$176.76
24-Stunden-Volumen:
4.41M
Relative Volume:
1.01
Marktkapitalisierung:
$127.85B
Einnahmen:
$24.78B
Nettoeinkommen (Verlust:
$3.68B
KGV:
34.91
EPS:
5.1743
Netto-Cashflow:
$5.29B
1W Leistung:
-7.60%
1M Leistung:
-0.48%
6M Leistung:
-18.27%
1J Leistung:
-8.37%
1-Tages-Spanne:
$176.51
$181.45
1-Wochen-Bereich:
$175.00
$200.50
52-Wochen-Spanne:
$175.00
$242.80
Danaher Corp Stock (DHR) Company Profile
Firmenname
Danaher Corp
Sektor
Branche
Telefon
(202) 828-0850
Adresse
2200 PENNSYLVANIA AVE. N.W., WASHINGTON, DC
Compare DHR vs TMO, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DHR
Danaher Corp
|
180.64 | 125.45B | 24.78B | 3.68B | 5.29B | 5.1743 |
TMO
Thermo Fisher Scientific Inc
|
468.10 | 174.55B | 45.20B | 6.88B | 6.75B | 18.19 |
IDXX
Idexx Laboratories Inc
|
574.95 | 44.95B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
115.62 | 32.65B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
299.79 | 30.42B | 3.17B | 642.63M | 516.49M | 10.77 |
Danaher Corp Stock (DHR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Goldman | Buy |
| 2025-12-02 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-10-08 | Herabstufung | Rothschild & Co Redburn | Buy → Neutral |
| 2025-07-11 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2025-04-10 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-03-21 | Hochstufung | Goldman | Neutral → Buy |
| 2025-03-14 | Hochstufung | Stifel | Hold → Buy |
| 2025-02-03 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-12-23 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-12-19 | Eingeleitet | Guggenheim | Buy |
| 2024-12-13 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-10-31 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2024-10-01 | Eingeleitet | Stephens | Overweight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-04-17 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-01-24 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2023-12-18 | Eingeleitet | HSBC Securities | Hold |
| 2023-12-13 | Fortgesetzt | Wolfe Research | Peer Perform |
| 2023-12-07 | Herabstufung | Goldman | Buy → Neutral |
| 2023-07-19 | Eingeleitet | Raymond James | Outperform |
| 2023-05-01 | Eingeleitet | SVB Securities | Outperform |
| 2023-04-26 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-04-18 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-01-05 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-10-24 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-08-17 | Fortgesetzt | Bernstein | Outperform |
| 2022-07-20 | Eingeleitet | UBS | Buy |
| 2022-06-01 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-01-11 | Eingeleitet | Bernstein | Outperform |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-09-10 | Bestätigt | BofA Securities | Buy |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-23 | Bestätigt | Goldman | Buy |
| 2021-07-16 | Eingeleitet | The Benchmark Company | Buy |
| 2021-04-07 | Fortgesetzt | Robert W. Baird | Outperform |
| 2021-03-03 | Fortgesetzt | Barclays | Overweight |
| 2020-12-02 | Eingeleitet | Goldman | Buy |
| 2020-11-25 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-06-16 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-04-02 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-03-26 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-02-03 | Bestätigt | Needham | Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Fortgesetzt | Stifel | Hold |
| 2019-10-28 | Bestätigt | Needham | Buy |
| 2019-10-14 | Fortgesetzt | Credit Suisse | Outperform |
| 2019-07-19 | Bestätigt | Needham | Buy |
| 2019-06-11 | Eingeleitet | Piper Jaffray | Neutral |
| 2019-05-30 | Eingeleitet | Wolfe Research | Outperform |
| 2019-04-17 | Bestätigt | Needham | Buy |
| 2019-02-28 | Bestätigt | Needham | Buy |
| 2019-02-25 | Hochstufung | Janney | Neutral → Buy |
| 2019-01-03 | Eingeleitet | Needham | Buy |
| 2018-04-20 | Bestätigt | Stifel | Buy |
Alle ansehen
Danaher Corp Aktie (DHR) Neueste Nachrichten
Danaher Corp. may be the smartest bet in biotech right now - MSN
Danaher Stock Forecast: What Is Driving Market Focus - Kalkine Media
State of Michigan Retirement System Decreases Holdings in Danaher Corporation $DHR - MarketBeat
Advisors Capital Management LLC Has $12.56 Million Stock Position in Danaher Corporation $DHR - MarketBeat
Danaher Corp. stock (US2358511028): Why Google Discover changes matter more now - AD HOC NEWS
Biotech Stocks To Keep An Eye OnApril 26th - MarketBeat
Vanguard Group Inc. Has $13.96 Billion Position in Danaher Corporation $DHR - MarketBeat
Danaher Corp. stock underperforms Wednesday when compared to competitors - MSN
Danaher Corporation $DHR Shares Purchased by AEGON ASSET MANAGEMENT UK Plc - MarketBeat
Danaher (NYSE:DHR) Falls After Argus Cut, S&P 500 Outlook Mixed - Kalkine Media
Danaher deal finalized: Company to acquire Masimo for $9.9 billion in cash - MSN
Danaher Corporation (DHR) Reports Q1 Adjusted EPS Beat - Insider Monkey
Argus Issues Pessimistic Forecast for Danaher (NYSE:DHR) Stock Price - MarketBeat
Impax Asset Management Group plc Sells 51,641 Shares of Danaher Corporation $DHR - MarketBeat
This Stock Is Up Over 52,700% Since Founding. Should Investors Buy After Its 36% Decline? - AOL.com
Danaher Corporation $DHR is Montrusco Bolton Investments Inc.'s 6th Largest Position - MarketBeat
Teacher Retirement System of Texas Decreases Holdings in Danaher Corporation $DHR - MarketBeat
Coronation Fund Managers Ltd. Boosts Stake in Danaher Corporation $DHR - MarketBeat
Danaher (NYSE:DHR) Cut to Hold at Wall Street Zen - MarketBeat
Danaher Execs Face Investor Suit Over Post-COVID Outlook - Law360
Danaher Q1 earnings beat estimates, life sciences sales up Y/Y - MSN
This Stock Is Up Over 52,700% Since Founding. Should Investors Buy After Its 36% Decline? - The Motley Fool
Danaher to Acquire Masimo Diagnostics in $9.9B Deal - USA Herald
M&T Bank Corp Cuts Stake in Danaher Corporation $DHR - MarketBeat
Arizona State Retirement System Sells 6,790 Shares of Danaher Corporation $DHR - MarketBeat
DHR Stock Price, Quote & Chart | DANAHER CORP (NYSE:DHR) - ChartMill
Danaher executive joins Avantor to lead product unit and Revival - Stock Titan
Danaher (DHR) sells €3.0B of notes; proceeds to help fund Masimo acquisition - Stock Titan
Danaher Corp. stock outperforms competitors despite losses on the day - MarketWatch
Danaher reaches $172.5 million settlement with shareholders over post-pandemic outlook - Reuters
Biotech Stocks To Follow NowApril 23rd - MarketBeat
Why Danaher Keeps Drawing Eyes In NYSE Composite? - Kalkine Media
Danaher Settles Investor Suit Over Projections for $173 Million - Bloomberg Law News
Danaher (NYSE:DHR) Reaches New 52-Week Low After Analyst Downgrade - MarketBeat
Danaher (NYSE:DHR) Given New $255.00 Price Target at Morgan Stanley - MarketBeat
OLD National Bancorp IN Has $19.20 Million Stock Position in Danaher Corporation $DHR - MarketBeat
Danaher Corporation stock hits 52-week low at $180.00 - Investing.com
Loring Wolcott & Coolidge Fiduciary Advisors LLP MA Has $391.12 Million Stock Holdings in Danaher Corporation $DHR - MarketBeat
Juno Financial Group LLC Makes New Investment in Danaher Corporation $DHR - MarketBeat
United Asset Strategies Inc. Purchases 9,953 Shares of Danaher Corporation $DHR - MarketBeat
Danaher prices €3 billion senior notes offering By Investing.com - Investing.com Australia
Danaher Corp (DHR) Shares Fall 5.4% -- What GF Score of 80 Tells Investors - GuruFocus
Danaher prices €3 billion senior notes offering - Investing.com
Danaher Corp estimates net proceeds from senior notes sale at 2.98 billion euros - marketscreener.com
Danaher Corp Estimates Net Proceeds From Senior Notes Sale At 2.98 Billion Euros - TradingView
Danaher Announces Pricing of Euro-Denominated Senior Notes Offering - marketscreener.com
Danaher CorpEstimates Net Proceeds From Se - Moomoo
To help fund its Masimo acquisition, Danaher prices €3B debt - Stock Titan
Danaher Corp files for four-part senior notes offering of up to EUR3 billionSEC filing - marketscreener.com
Danaher (NYSE:DHR) Given New $250.00 Price Target at UBS Group - MarketBeat
Morgan Stanley Cuts Price Target on Danaher to $255 From $270 - marketscreener.com
Finanzdaten der Danaher Corp-Aktie (DHR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Danaher Corp-Aktie (DHR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Milosevich Gregory M | Executive Vice President |
Feb 19 '26 |
Sale |
208.01 |
1,320 |
274,575 |
5,099 |
0.42%
1.37%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):